nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A phase I pharmacokinetic and pharmacodynamic study of the oral mitogen-activated protein kinase kinase (MEK) inhibitor, WX-554, in patients with advanced solid tumours
|
Jamieson, David |
|
2016 |
68 |
C |
p. 1-10 10 p. |
artikel |
2 |
Biology and treatment of renal tumours in childhood
|
Brok, Jesper |
|
2016 |
68 |
C |
p. 179-195 17 p. |
artikel |
3 |
6-C-(E-phenylethenyl)naringenin induces cell growth inhibition and cytoprotective autophagy in colon cancer cells
|
Zhao, Yueliang |
|
2016 |
68 |
C |
p. 38-50 13 p. |
artikel |
4 |
Comments on “Proposal and validation of a new model to estimate survival for hepatocellular carcinoma patients”
|
Sang, Wei |
|
2016 |
68 |
C |
p. 203-205 3 p. |
artikel |
5 |
Concurrent irradiation with the anti-programmed cell death ligand-1 immune checkpoint blocker durvalumab: Single centre subset analysis from a phase 1/2 trial
|
Levy, Antonin |
|
2016 |
68 |
C |
p. 156-162 7 p. |
artikel |
6 |
Corrigendum to “2nd St. Gallen EORTC Gastrointestinal Cancer Conference: Consensus recommendations on controversial issues in the primary treatment of rectal cancer” [Eur J Cancer 63 (August 2016) 11–24]
|
Lutz, Manfred P. |
|
2016 |
68 |
C |
p. 208-209 2 p. |
artikel |
7 |
Do aromatase inhibitors increase cardiovascular risk? Piecing together the evidence
|
Desautels, Danielle N. |
|
2016 |
68 |
C |
p. 176-178 3 p. |
artikel |
8 |
Early tumour response as a survival predictor in previously- treated patients receiving triplet hepatic artery infusion and intravenous cetuximab for unresectable liver metastases from wild-type KRAS colorectal cancer
|
Bouchahda, Mohamed |
|
2016 |
68 |
C |
p. 163-172 10 p. |
artikel |
9 |
Eliciting regret improves decision making at the end of life
|
Djulbegovic, Benjamin |
|
2016 |
68 |
C |
p. 27-37 11 p. |
artikel |
10 |
Final results and outcomes by prior bevacizumab exposure, skin toxicity, and hypomagnesaemia from ASPECCT: randomized phase 3 non-inferiority study of panitumumab versus cetuximab in chemorefractory wild-type KRAS exon 2 metastatic colorectal cancer
|
Price, Timothy |
|
2016 |
68 |
C |
p. 51-59 9 p. |
artikel |
11 |
Immunotherapy for rectal carcinoma: Some stimulating data but still a long way to clinical evidence
|
Gérard, Jean-Pierre |
|
2016 |
68 |
C |
p. 70-72 3 p. |
artikel |
12 |
Impact of variations in triage cytology interpretation on human papillomavirus–based cervical screening and implications for screening algorithms
|
Ronco, Guglielmo |
|
2016 |
68 |
C |
p. 148-155 8 p. |
artikel |
13 |
Letter response: Methadone is superior to fentanyl in treating neuropathic pain in patients with head-and-neck cancer
|
Haumann, J. |
|
2016 |
68 |
C |
p. 201-202 2 p. |
artikel |
14 |
Letter to the Editor, Re: van der Heijden AG, Mengual L, Lozano JJ, Ingelmo-Torres M, Ribal MJ, Fernández PL, Oosterwijk E, Schalken JA, Alcaraz A, Witjes JA. A five-gene expression signature to predict progression in T1G3 bladder cancer. Eur J Cancer. 2016; 64:127–136
|
Orsola, Anna |
|
2016 |
68 |
C |
p. 196-197 2 p. |
artikel |
15 |
Methadone is superior to fentanyl in treating neuropathic pain in patients with head-and-neck cancer
|
Ruan, Xiulu |
|
2016 |
68 |
C |
p. 199-200 2 p. |
artikel |
16 |
Precision medicine in diffuse large B-cell lymphoma: Hype or hope?
|
Prasad, Vinay |
|
2016 |
68 |
C |
p. 22-26 5 p. |
artikel |
17 |
Quantitative analysis of microcirculation blood perfusion in patients with hepatocellular carcinoma before and after transcatheter arterial chemoembolisation using contrast-enhanced ultrasound
|
Tian, Hui |
|
2016 |
68 |
C |
p. 82-89 8 p. |
artikel |
18 |
Reply to letter commenting on: A five-gene expression signature to predict progression in T1G3 bladder cancer
|
van der Heijden, Antoine G. |
|
2016 |
68 |
C |
p. 198- 1 p. |
artikel |
19 |
Ruthenium-106 brachytherapy for choroidal melanoma without transpupillary thermotherapy: Similar efficacy with improved visual outcome
|
Marinkovic, Marina |
|
2016 |
68 |
C |
p. 106-113 8 p. |
artikel |
20 |
The blockage of Notch signalling promoted the generation of polymorphonuclear myeloid-derived suppressor cells with lower immunosuppression
|
Wang, Shu-Hong |
|
2016 |
68 |
C |
p. 90-105 16 p. |
artikel |
21 |
The 21-gene recurrence score assay in node-negative early breast cancer: Prognostic, predictive or presumptuous?
|
Jerzak, Katarzyna J. |
|
2016 |
68 |
C |
p. 173-175 3 p. |
artikel |
22 |
The risk of myocardial infarction with aromatase inhibitors relative to tamoxifen in post-menopausal women with early stage breast cancer
|
Abdel-Qadir, Husam |
|
2016 |
68 |
C |
p. 11-21 11 p. |
artikel |
23 |
The role of galectin-1 in in vitro and in vivo photodynamic therapy with a galactodendritic porphyrin
|
Pereira, Patrícia M.R. |
|
2016 |
68 |
C |
p. 60-69 10 p. |
artikel |
24 |
The role of S100a4 (Mts1) in Apc- and Smad4-driven tumour onset and progression
|
Atlasi, Yaser |
|
2016 |
68 |
C |
p. 114-124 11 p. |
artikel |
25 |
The use of EORTC measures in daily clinical practice—A synopsis of a newly developed manual
|
Wintner, Lisa M. |
|
2016 |
68 |
C |
p. 73-81 9 p. |
artikel |
26 |
Treatment de-intensification strategies for head and neck cancer
|
Kelly, Jacqueline R. |
|
2016 |
68 |
C |
p. 125-133 9 p. |
artikel |
27 |
Turning tumour cells into antigen presenting cells: The next step to improve cancer immunotherapy?
|
de Charette, Marie |
|
2016 |
68 |
C |
p. 134-147 14 p. |
artikel |
28 |
Utility of prognostic scoring systems in management of hepatocellular carcinoma
|
Liu, Po-Hong |
|
2016 |
68 |
C |
p. 206-207 2 p. |
artikel |